STING1 and melanoma: Similar upregulation of these phosphorylated signaling intermediates was also observed in both B16F10 melanoma cells and NK92 cells following H62 exposure (Fig. 4B-C, Fig. S12B-C), confirming STING pathway activation in both tumor and immune effector cells.